Press Releases
Public Relations: Andrew Noble
DNAnexus Wins BioTech Breakthrough Award For BioInformatics Solution of the Year
Annual Awards Program Recognizes Innovation in the Global Life Science and Biotechnology Industries.
DNAnexus Strengthens Leadership Team to Drive Ongoing Product Innovation and Commercial Growth
Company appoints healthcare technology industry veterans Nupura Kolwalkar as Chief Product Officer and Bill Madigan as Chief Commercial Officer.
DNAnexus and Galatea Bio Launch Collaboration to Enhance Precision Medicine with Advanced Genetic Tools for Underserved Populations
Under the new agreement, Galatea Bio will use DNAnexus' Precision Health Data Cloud to increase the availability and speed of the analysis of its diverse non-European datasets. Importantly, this collaboration will allow DNAnexus' extensive network of more than 48,000 users across 48 countries to potentially leverage Galatea’s advanced local ancestry and ancestry-adjusted PRS (polygenic risk score) algorithms.
UK Biobank and DNAnexus Collaboration Earns Bio-IT World 2024 Innovative Best Practices Global Impact Award for 500,000 Whole Genomes Data Release
DNAnexus and Oracle Collaborate to Advance Precision Health
We are excited to announce we have teamed up with Oracle to advance precision health by connecting our respective ecosystems. The DNAnexus platform will be seamlessly available to global Oracle Cloud Infrastructure, Oracle Health, and Oracle Database customers. In addition, customers will be able to use OCI integration services for their healthcare applications. DNAnexus customers will be able to leverage Oracle’s expertise in accelerating AI pipelines and its industry partnerships to bring global customers even faster genomic analysis and better AI models.
DNAnexus Adds NVIDIA NIM and CUDA-X Microservices to Precision Health Data Cloud to Accelerate Drug Discovery and Improve Patient Care
New Universal DeepVariant is one microservice compatible across multiple sequencing platforms and is designed to deliver more than 50x acceleration compared to CPU
DNAnexus to Showcase the Power of High-Value Multi-Omics Data at the Precision Medicine in IBD Summit
Co-founder of Ovation to share how researchers are using DNAnexus’ Precision Health Data Cloud to streamline analysis, identify optimal therapeutic targets, and advance drug discovery.
DNAnexus and Curio Bioscience Announce Collaboration to Streamline and Simplify Data Analysis for Large-Scale Spatial Transcriptomics Projects
Combination of Curio Seeker with Precision Health Data Cloud provides scientists with a secure and scalable solution for managing and sharing high-resolution, spatially resolved gene expression data.
DNAnexus and LORENZ Partner to Enable Collaborative Regulatory Submission Validation and Scientific Review in the Cloud via Trusted Regulatory Spaces
Companies have joined with industry leaders and FDA on Project PRISM to advance solutions that can improve the submission, review and ease of communication for human drug and biologics applications.
Element Biosciences and DNAnexus® Announce Collaboration to Advance Multi-Omics Analysis
Direct integration allows customers to stream data from Element’s AVITI™ System directly to DNAnexus.
News
The Rise and Importance of Population-Scale Genome Programs
With the wealth of population-scale projects going on, we have entered a golden age of genomics. Based on efforts such as the All of Us program in the U.S. and the UK Biobank, among many others, we are poised to discover more than we ever knew about natural genetic diversity, what’s considered “normal” human biology, and the continuum of health and disease.
World’s largest genetic project opens the door to new era for treatments and cures: UK Biobank’s major milestone
In a momentous landmark for medical research, UK Biobank has today unveiled incredible new data from whole genome sequencing of its half a million participants. This is set to drive the discovery of new diagnostics, treatments and cures and, uniquely, is available to approved researchers worldwide, via a protected database containing only de-identified data (e.g. name, address, date of birth, name of GP and more stripped out).
DNAnexus included in Fast Company's 10 most innovative biotech companies of 2023
Among the 2023 Most Innovative Companies in Biotech, Fast Company is recognizing breakthroughs in DNA sequencing and spatial transcriptomics, along with innovations in biological-specimen sourcing, cell-separation technology, and the production of synthetic antibodies.
Blackstone Growth Leads $200 Million Investment in DNAnexus
"Collaboration is vital to advancing scientific discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward finding cures for pediatric cancer and other life-threatening diseases."
James R. Downing
President & CEO
St. Judes Children’s Research Hospital